ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma

By N. Concin, X. Matías-Guiu, I. Vergote, D. Cibula, M. Mirza, S. Marnitz, Jonathan A. Ledermann, T. Bosse, Cyrus Chargari, A. Fagotti and 18 more. International Journal of Gynecological Cancer, 2020

1,756 citations recorded by the source corpus.

A European consensus conference on endometrial carcinoma was held in 2014 to produce multi-disciplinary evidence-based guidelines on selected questions. Given the large body of literature on the management of endometrial carcinoma published since 2014, the European Society of Gynaecological Oncology (ESGO), the European SocieTy for Radiotherapy and Oncology (ESTRO), and the European Society of Pathology (ESP) jointly decided to update these evidence-based guidelines and to cover new topics in order to improve the quality of care for women with endometrial carcinoma across Europe and worldwide.

Subfields: Epidemiology, Obstetrics and Gynecology, Reproductive Medicine

View Paper: https://www.semanticscholar.org/paper/ed10de4457bd399865df7f79d83c06bbb5d2bf5c

Citations in the corpus

• FIGO staging of endometrial cancer: 2023 (2023, neutral): “80,81 Therefore, it was determined that notation of the molecular classification, when performed, should be included to stage the patient's disease.”